Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001810417-26-000021 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
30,555
Total Value
$261,344.04
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Sep 10, 2026 | Exercise/Conversion | 10,185 | $8.04 | $81,887.40 | 50,085 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Sep 10, 2026 | Sale | 10,185 | $17.62 | $179,456.64 | 39,900 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Sep 10, 2026 | Exercise/Conversion | 10,185 | $0.00 | $0.00 | 105,815 | Direct | โ | View Details |